Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
PMV Pharmaceuticals, Inc. (PMVP) had Income from Continuous Operations of $-21.06M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-21.06M |
|
-- |
|
-- |
|
$22.52M |
|
$-22.52M |
|
$1.46M |
|
$-21.07M |
|
$-21.07M |
|
$-21.06M |
|
|
Income from Continuous Operations |
$-21.06M |
$-21.06M |
|
$-21.06M |
|
$-22.52M |
|
$-23.18M |
|
52.99M |
|
52.99M |
|
$-0.40 |
|
$-0.40 |
|
| Balance Sheet Financials | |
$132.45M |
|
$0.26M |
|
$1.40M |
|
$133.84M |
|
$12.30M |
|
-- |
|
$0.54M |
|
$12.85M |
|
$121.00M |
|
$121.00M |
|
$121.00M |
|
52.99M |
|
| Cash Flow Statement Financials | |
$-56.39M |
|
$51.73M |
|
$0.11M |
|
$40.88M |
|
$36.34M |
|
$-4.54M |
|
$4.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.76 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-56.37M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-17.40% |
|
-17.40% |
|
-15.73% |
|
-17.40% |
|
$2.28 |
|
$-1.06 |
|
$-1.06 |
|